BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10686001)

  • 1. High platelet contamination in progenitor cell concentrates results in significantly lower CD34+ yield after immunoselection.
    Reiser M; Draube A; Scheid C; Fuchs M; Josting A; Diehl V; Söhngen D
    Transfusion; 2000 Feb; 40(2):178-81. PubMed ID: 10686001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow versus peripheral blood progenitor cells CD34 selection in patients with non-Hodgkin's lymphomas: different levels of tumor cell reduction. Implications for autografting.
    Lopez M; Lemoine FM; Firat H; Fouillard L; Laporte JP; Lesage S; Isnard F; Stachowiak J; Ferrer-Le Coeur F; Morel P; Najman A; Douay L; Gorin NC
    Blood; 1997 Oct; 90(7):2830-8. PubMed ID: 9326252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD34+ selection of hematopoietic blood cell collections and autotransplantation in lymphoma: overnight storage of cells at 4 degrees C does not affect outcome.
    Lazarus HM; Pecora AL; Shea TC; Koç ON; White JM; Gabriel DA; Cooper BW; Gerson SL; Krieger M; Sing AP
    Bone Marrow Transplant; 2000 Mar; 25(5):559-66. PubMed ID: 10713636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled comparison of two different clinical grade devices for CD34+ cell selection of autologous blood stem cell grafts.
    Björkstrand B; Sundman-Engberg B; Christensson B; Kumlien G
    J Hematother; 1999 Feb; 8(1):75-80. PubMed ID: 10192304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous CD34+ cell transplantation for patients with advanced lymphoma: effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment.
    Koç ON; Gerson SL; Phillips GL; Cooper BW; Kutteh L; Van Zant G; Reece DE; Fox RM; Schupp JE; Tainer N; Lazarus HM
    Bone Marrow Transplant; 1998 Feb; 21(4):337-43. PubMed ID: 9509966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intermittent- and continuous-flow cell separators for the collection of autologous peripheral blood progenitor cells in patients with hematologic malignancies.
    Hitzler WE; Wolf S; Runkel S; Kunz-Kostomanolakis M
    Transfusion; 2001 Dec; 41(12):1562-6. PubMed ID: 11778073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two leukapheresis programs for computerized collection of blood progenitor cells on a new cell separator.
    Schwella N; Movassaghi K; Scheding S; Ahrens N; Salama A
    Transfusion; 2003 Jan; 43(1):58-64. PubMed ID: 12519431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection.
    Engelhardt M; Bertz H; Afting M; Waller CF; Finke J
    J Clin Oncol; 1999 Jul; 17(7):2160-72. PubMed ID: 10561272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the effect of Cobe Spectra and Fenwal CS 3000 plus blood cell separators in collection of peripheral blood stem cell components].
    Yang SM; Liu KY; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):245-9. PubMed ID: 15854285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose CD34+ cells are not clinically relevant in reducing cytopenia and blood component consumption following myeloablative therapy and peripheral blood progenitor cell transplantation as compared with standard dose.
    Lefrère F; Delarue R; Somme D; Levy V; Damaj G; Tu A; Porcher R; Audat F; Boulat C; Cavazzana-Calvo M; Buzyn A; Belanger C; Maillard N; Hermine O; Varet B
    Transfusion; 2002 Apr; 42(4):443-50. PubMed ID: 12076291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma.
    Moskowitz CH; Glassman JR; Wuest D; Maslak P; Reich L; Gucciardo A; Coady-Lyons N; Zelenetz AD; Nimer SD
    Clin Cancer Res; 1998 Feb; 4(2):311-6. PubMed ID: 9516916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomized trial of two popular mononuclear cell collection sets for autologous peripheral blood stem cell collection in multiple myeloma.
    Cooling L; Hoffmann S; Herrst M; Muck C; Armelagos H; Davenport R
    Transfusion; 2010 Jan; 50(1):100-19. PubMed ID: 19719472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive selection of CD34+ cells from cryopreserved peripheral blood stem cells after thawing: technical aspects and clinical use.
    Bohbot A; Lioure B; Faradji A; Schmitt M; Cuillerot JM; Laplace A; Oberling F
    Bone Marrow Transplant; 1996 Feb; 17(2):259-64. PubMed ID: 8640176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo expansion of CD34+ peripheral blood progenitor cells: implications for the expansion of contaminating epithelial tumor cells.
    Vogel W; Behringer D; Scheding S; Kanz L; Brugger W
    Blood; 1996 Oct; 88(7):2707-13. PubMed ID: 8839866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
    Callera F; Cavenaghi L; de Melo CM
    Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD34+-selected peripheral blood progenitor cell transplantation in patients with multiple myeloma: tumour cell contamination and outcome.
    Gupta D; Bybee A; Cooke F; Giles C; Davis JG; McDonald C; Armitage SE; McGuigan D; Lyttelton MP; Kanfer EJ; Apperley JF; Samson D
    Br J Haematol; 1999 Jan; 104(1):166-77. PubMed ID: 10027730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization.
    Passos-Coelho JL; Braine HG; Davis JM; Huelskamp AM; Schepers KG; Ohly K; Clarke B; Wright SK; Noga SJ; Davidson NE
    J Clin Oncol; 1995 Mar; 13(3):705-14. PubMed ID: 7533827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of high yield and purify of CD34(+) cell-selected PBPC, collected from patients with multiple myeloma.
    Webb IJ; Scholssman RL; Jiroutek M; Doss D; Cohen CA; Freeman A; Schott DM; Anderson KC
    Cytotherapy; 1999; 1(3):175-82. PubMed ID: 12881173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric peripheral blood progenitor cell collection: haemonetics MCS 3P versus COBE Spectra versus Fresenius AS104.
    Bambi F; Faulkner LB; Azzari C; Gelli AM; Tamburini A; Tintori V; Lippi AA; Tucci F; Bernini G; Genovese F
    Transfusion; 1998 Jan; 38(1):70-4. PubMed ID: 9482397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined isolation of CD34+ progenitor cells and reduction of B cells from peripheral blood by use of immunomagnetic methods.
    Martín-Henao GA; Picón M; Rueda F; Amill B; Querol S; Gonzalez-Barca E; Ferrá C; Grañena A; García J
    Transfusion; 2002 Jul; 42(7):912-20. PubMed ID: 12375665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.